icone plus
Contact
Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
wUyUB8s5mwHfyrWb